After it was confirmed that both the mRNA and protein levels of PHD3 and FIH were obviously reduced in tumor tissue, we were notably interested in whether these changes had any correlation with the clinicopathological features of HCC patients. This evidence concerns the gene EGLN3 and hepatocellular carcinoma.